Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06334926
Status:
COMPLETED
Last Update Posted:
2024-03-28
First Post:
2024-03-21
Brief Title:
BMI and Lymph Node Count in Colorectal Cancer
Sponsor:
Klinikum Floridsdorf
Organization:
Klinikum Floridsdorf
Study Overview
Official Title:
Prediction of Survival in Colorectal Cancer Patients on the Basis of Body Mass Index and Lymph Node Yield - a Retrospective Single Center Cohort Analysis Over a Quarter of a Century
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background and aim Colorectal Cancer CRC is one of the most frequent cancer entities in the western world It is known that obesity is one of the major risk factors for CRC In contrast mild obesity seems to have a positive effect on postoperative outcome which is known as the obesity paradox Also the number of resected lymph nodes LN during surgery is very important for correct staging The aim of the present project is to evaluate the impact of BMI and LN-yield on long term overall survival OS of CRC patients treated with curative intent
Methods Patients treated for CRC between 1998 and 2011 at the Klinik Favoriten in Vienna Austria were analyzed in this retrospective single-center cohort analysis concerning OS
Methods Patients treated for CRC between 1998 and 2011 at the Klinik Favoriten in Vienna Austria were analyzed in this retrospective single-center cohort analysis concerning OS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None